Intuitive Surgical (NASDAQ:ISRG) EVP Mark Brosius Sells 77 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Mark Brosius sold 77 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $394.26, for a total value of $30,358.02. Following the transaction, the executive vice president owned 1,035 shares of the company’s stock, valued at $408,059.10. This represents a 6.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Brosius also recently made the following trade(s):

• On Monday, August 17th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $390.67, for a total value of $30,081.59.
• On Friday, July 31st, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $351.00, for a total transaction of $9,828.00.
• On Wednesday, July 29th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $360.21, for a total transaction of $10,085.88.
• On Monday, July 27th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $344.00, for a total value of $9,632.00.
• On Friday, June 12th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The shares were sold at an average price of $414.13, for a total value of $10,353.25.
• On Wednesday, June 10th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $424.14, for a total transaction of $9,755.22.
• On Monday, June 8th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $420.12, for a total transaction of $9,662.76.
• On Friday, May 22nd, Mark Brosius sold 18 shares of Intuitive Surgical stock. The stock was sold at an average price of $439.80, for a total value of $7,916.40.

Intuitive Surgical Trading Up 1.7%

ISRG opened at $397.72 on Thursday. The company has a fifty day moving average price of $389.89 and a two-hundred day moving average price of $438.02. The company has a market cap of $140.51 billion, a P/E ratio of 45.56, a price-to-earnings-growth ratio of 2.83 and a beta of 1.46. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.48 by $0.32. The company had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.81 earnings per share. On average, research analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms recently commented on ISRG. Sanford C. Bernstein restated an “outperform” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Wells Fargo & Company reissued an “overweight” rating and issued a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, August 14th. UBS Group began coverage on Intuitive Surgical in a research note on Tuesday, July 28th. They issued a “neutral” rating and a $500.00 price target for the company. Finally, Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, August 15th. Twenty-two research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $508.68.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. State Street Corp grew its stake in shares of Intuitive Surgical by 1.0% in the fourth quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider’s stock worth $8,892,753,000 after acquiring an additional 162,264 shares during the period. Capital World Investors raised its stake in Intuitive Surgical by 1.7% during the 4th quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock valued at $4,449,491,000 after buying an additional 127,526 shares during the last quarter. Norges Bank bought a new position in shares of Intuitive Surgical during the 4th quarter valued at $2,856,987,000. Invesco Ltd. boosted its stake in shares of Intuitive Surgical by 17.4% in the 4th quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock worth $2,338,350,000 after buying an additional 611,268 shares during the last quarter. Finally, Bank of America Corp DE grew its holdings in shares of Intuitive Surgical by 3.3% in the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after acquiring an additional 116,292 shares during the period. 83.64% of the stock is owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.